F
$ Value
$7K
Shares
498
Price
$14
Filed
Dec 3
Insider
Name
Luu Brendan
Title
Chief Business Officer
CIK
0001842369
Roles
Officer
Transaction Details
Transaction Date
2025-12-01
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
39,723
Footnotes
Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021.
Filing Info
Luu Brendan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | F | $46K |
| 2025-12-05 | ENTA | ▼ | $20K |
| 2025-12-01 | ENTA | F | $7K |
| 2025-11-25 | ENTA | A | $0 |
Other Insiders at ENTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER BRUCE L A | — | — | 2026-03-11 |
| FOLETTA MARK G | — | — | 2026-03-11 |
| Russell Lesley | — | — | 2026-03-11 |
| Peterson Kristine | — | — | 2026-03-11 |
|
Luly Jay R.
President and CEO
|
— | — | 2026-02-12 |
|
Or Yat Sun
Chief Scientific Officer
|
— | — | 2026-02-12 |
| Vance Terry | — | — | 2026-03-11 |
| Hata Yujiro S | — | — | 2026-03-11 |
|
Kowalsky Matthew Paul
Chief Legal Officer
|
— | — | 2026-02-12 |
|
Kieffer Tara Lynn
Chief Product Strategy Officer
|
— | — | 2026-02-12 |
|
Luu Brendan
Chief Business Officer
|
— | — | 2026-02-12 |
|
Rottinghaus Scott T.
Chief Medical Officer
|
— | — | 2026-02-12 |